U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056556) titled 'A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors' on June 30.
Brief Summary: This study is an open-label, multicenter, dose-escalation and cohort-expansion, non-randomized Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M09D1 for injection in patients with locally advanced or metastatic non-small cell lung cancer and other solid tumors.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Non-small Cell Lung Cancer
Solid Tumor
Intervention:
DRUG: BL-M09D1
Administratio...